Monday, June 15, 2026

CES 2026: Medicube’s Beauty Tech Innovations Captivate 1,600 Visitors – What You Need to Know

APR Co Ltd successfully showcased its Medicube beauty tech at CES 2026, attracting 1,600 visitors and planning global expansion.

New Hope for Alcohol-Related Liver Disease: GLP-1 Drugs Show Promise

Research shows that GLP-1 receptor agonists, like Wegovy, may help combat alcohol-related liver disease, reducing liver cancer risk.

Tesla, Rivian, and Lucid Surge in EV Rally—But Nikola Takes a 12% Dive

U.S. EV stocks surged, led by Tesla's 5.77% gain, while Nikola fell 12.80% amid financial struggles and speculation.

Sang In Yang

The Cells That Start It All: KAIST Breaks Ground in Brain Cancer Research

Researchers at KAIST have identified precancerous cells in glioblastoma, revealing their role in tumor evolution and treatment resistance.

KAIST’s Brain-Inspired Chip Could Be the Future of AI Processing

KAIST's Dr. Kim Kyung Min developed the Neuransistor, a semiconductor mimicking brain neuron functions for faster data processing.

New Drug Candidate Shows Promise Against Solid Tumors by Eliminating M2 Macrophages

Researchers have developed a peptide drug that targets M2 macrophages, enhancing solid tumor immunotherapy effectiveness.

New Battery Tech Could Power Your Phone Longer—Even in 122°F Heat

A South Korean team has developed a nanoparticle electrolyte for lithium metal batteries, enhancing performance and lifespan significantly.

No Cooling Required: KAIST’s Tiny Sensor Sees What the Eye Can’t

KAIST's research team developed a groundbreaking mid-infrared photodetector that operates at room temperature without cooling systems.

KAIST Develops New Bioplastic That Rivals Petroleum-Based Plastics

KAIST researchers engineered a microbe to produce biodegradable polyester amide from glucose, offering a sustainable plastic alternative.

KAIST’s vTrain Reduces Training Costs and Increases Efficiency for AI Models

KAIST's vTrain tool optimizes LLM training time, improving GPU efficiency by 10% and reducing costs by over 5%, now open-source.

Top News

- Our Sponsors Ad -

Follow us